PEG-MGF: what it is and what the evidence says
MGF with polyethylene glycol attached to prolong its time in the bloodstream. The modification comes from manufacturing, not from clinical research.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
Tissue repair happens in phases, not all at once: an initial inflammation that is actually useful, the building of new tissue, and then its remodelling, which can take months. Compounds studied in this area relate to one of those phases. None of them replaces rest or rehabilitation, and that is precisely the most common mistake people make when reading about them.
What it is studied for
Advertised for muscle repair.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
There is absolutely no evidence in humans: no clinical trials, no pharmacokinetics, no safety data. The only indexed work consists of analytical chemistry papers characterising it in BLACK MARKET products and methods for detecting it in anti-doping control.
The limitation that matters most
It does not even inherit solid preclinical backing, because non-pegylated MGF itself remains experimental. On top of that, the products in circulation are uncharacterised: analyses of seized material have found modified analogues different from what the label advertises, with unknown purity and pegylation.
Regulatory status
Not approved and not in clinical development. A grey-market product. Banned in sport (WADA S2).
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
Zero evidence in humans. Analyses of seized product found molecules different from those advertised.
Persistent pain, a muscle tear or a tendon problem serious enough to send someone looking for this product deserves an orthopaedic or physiotherapy assessment first, where treatments do have backing.
What this page cannot give you
A reference page can take you this far. You know what PEG-MGF is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a diploma with a verifiable folio, a record to track how you progress, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market productspreclinical Rapid Commun Mass Spectrom · 2012 · PMID 22328223 →
- Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23Hpreclinical Drug Test Anal · 2017 · PMID 28035768 →
- Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controlspreclinical Growth Horm IGF Res · 2014 · PMID 25466910 →
- Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrationspreclinical PLoS One · 2016 · PMID 26991004 →
- Research on mechano growth factor: its potential for optimising physical training as well as misuse in dopingreview Br J Sports Med · 2005 · PMID 16244184 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for PEG-MGF or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is PEG-MGF?
MGF with polyethylene glycol attached to prolong its time in the bloodstream. The modification comes from manufacturing, not from clinical research. It is studied within the area of regenerative.
Is there human evidence for PEG-MGF?
There is absolutely no evidence in humans: no clinical trials, no pharmacokinetics, no safety data. The only indexed work consists of analytical chemistry papers characterising it in BLACK MARKET products and methods for detecting it in anti-doping control.
Is it approved by any health agency?
Not approved and not in clinical development. A grey-market product. Banned in sport (WADA S2).
What is the dose of PEG-MGF?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what PEG-MGF is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.